|
|
|
|
| LEADER |
01326nam a2200253 u 4500 |
| 001 |
EB002010732 |
| 003 |
EBX01000000000000001173631 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
220201 r ||| eng |
| 100 |
1 |
|
|a Li, Ke Xin
|
| 245 |
0 |
0 |
|a Fecal occult blood testing in acute care settings
|h Elektronische Ressource
|b a review of clinical utility
|c authors, Ke Xin Li, Danielle MacDougall
|
| 250 |
|
|
|a Version: 1.0
|
| 260 |
|
|
|a Ottawa
|b Canadian Agency for Drugs and Technologies in Health
|c September 5, 2019, 2019
|
| 300 |
|
|
|a 1 PDF file (12 pages)
|b illustration
|
| 505 |
0 |
|
|a Includes bibliographical references
|
| 700 |
1 |
|
|a MacDougall, Danielle
|e [author]
|
| 710 |
2 |
|
|a Canadian Agency for Drugs and Technologies in Health
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 490 |
0 |
|
|a CADTH rapid response report: summary with critical appraisal
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK549530
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
| 082 |
0 |
|
|a 610
|
| 520 |
|
|
|a This review seeks to determine the updated clinical utility evidence since the 2017 CADTH Rapid Response Report regarding fecal occult blood tests for the identification of gastrointestinal bleeding in acute care settings outside of screening for colorectal cancer
|